0001193125-22-315417.txt : 20221230 0001193125-22-315417.hdr.sgml : 20221230 20221230160553 ACCESSION NUMBER: 0001193125-22-315417 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221230 FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VectivBio Holding AG CENTRAL INDEX KEY: 0001836379 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40316 FILM NUMBER: 221502035 BUSINESS ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 BUSINESS PHONE: 41 61 551 30 30 MAIL ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 6-K 1 d442175d6k.htm 6-K 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of December 2022

Commission File Number 001-40316

 

 

VECTIVBIO HOLDING AG

(Exact name of registrant as specified in its charter)

 

 

Aeschenvorstadt 36

4051 Basel

Switzerland

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☒             Form 40-F  ☐

 

 

 

Resignation of Director

On December 27, 2022, Chahra Louafi submitted her resignation from the Board of Directors of VectivBio Holding AG (the “Company”), which resignation was effective immediately. Ms. Louafi’s resignation was not the result of any disagreement with the Company.

Incorporation by Reference

The Company hereby incorporates by reference the information contained in the body of this Report on Form 6-K into the Company’s registration statements on Form S-8 (File No. 333-255524) and Form F-3 (File Nos. 333-264653 and 333-265546) (including any prospectuses forming a part of such registration statements) and deems them to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    VECTIVBIO HOLDING AG
December 30, 2022     By:  

/s/ Luca Santarelli

      Luca Santarelli
      Chief Executive Officer